Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 210

1.

CD22, a B lymphocyte-specific adhesion molecule that regulates antigen receptor signaling.

Tedder TF, Tuscano J, Sato S, Kehrl JH.

Annu Rev Immunol. 1997;15:481-504. Review.

PMID:
9143697
2.

Localization of the putative sialic acid-binding site on the immunoglobulin superfamily cell-surface molecule CD22.

van der Merwe PA, Crocker PR, Vinson M, Barclay AN, Schauer R, Kelm S.

J Biol Chem. 1996 Apr 19;271(16):9273-80.

3.
4.

CD22 associates with the human surface IgM-B-cell antigen receptor complex.

Leprince C, Draves KE, Geahlen RL, Ledbetter JA, Clark EA.

Proc Natl Acad Sci U S A. 1993 Apr 15;90(8):3236-40.

5.
7.

CD22 is both a positive and negative regulator of B lymphocyte antigen receptor signal transduction: altered signaling in CD22-deficient mice.

Sato S, Miller AS, Inaoki M, Bock CB, Jansen PJ, Tang ML, Tedder TF.

Immunity. 1996 Dec;5(6):551-62.

8.

Sialoadhesin, myelin-associated glycoprotein and CD22 define a new family of sialic acid-dependent adhesion molecules of the immunoglobulin superfamily.

Kelm S, Pelz A, Schauer R, Filbin MT, Tang S, de Bellard ME, Schnaar RL, Mahoney JA, Hartnell A, Bradfield P, et al.

Curr Biol. 1994 Nov 1;4(11):965-72.

PMID:
7533044
9.

Ig domains 1 and 2 of murine CD22 constitute the ligand-binding domain and bind multiple sialylated ligands expressed on B and T cells.

Law CL, Aruffo A, Chandran KA, Doty RT, Clark EA.

J Immunol. 1995 Oct 1;155(7):3368-76.

PMID:
7561031
10.

The amino-terminal immunoglobulin-like domain of sialoadhesin contains the sialic acid binding site. Comparison with CD22.

Nath D, van der Merwe PA, Kelm S, Bradfield P, Crocker PR.

J Biol Chem. 1995 Nov 3;270(44):26184-91.

11.

CD22 negatively and positively regulates signal transduction through the B lymphocyte antigen receptor.

Sato S, Tuscano JM, Inaoki M, Tedder TF.

Semin Immunol. 1998 Aug;10(4):287-97. Review.

PMID:
9695185
12.

Regulation of MHC class II signal transduction by the B cell coreceptors CD19 and CD22.

Bobbitt KR, Justement LB.

J Immunol. 2000 Nov 15;165(10):5588-96.

13.

CD19, CD21, and CD22: multifaceted response regulators of B lymphocyte signal transduction.

Poe JC, Hasegawa M, Tedder TF.

Int Rev Immunol. 2001;20(6):739-62. Review.

PMID:
11913948
14.

Association of CD22 with the B cell antigen receptor.

Peaker CJ, Neuberger MS.

Eur J Immunol. 1993 Jun;23(6):1358-63.

PMID:
7684686
15.
16.

CD22 associates with protein tyrosine phosphatase 1C, Syk, and phospholipase C-gamma(1) upon B cell activation.

Law CL, Sidorenko SP, Chandran KA, Zhao Z, Shen SH, Fischer EH, Clark EA.

J Exp Med. 1996 Feb 1;183(2):547-60.

17.

Transitional and marginal zone B cells have a high proportion of unmasked CD22: implications for BCR signaling.

Danzer CP, Collins BE, Blixt O, Paulson JC, Nitschke L.

Int Immunol. 2003 Oct;15(10):1137-47.

PMID:
13679384
18.

CD22 is a negative regulator of B-cell receptor signalling.

Nitschke L, Carsetti R, Ocker B, Köhler G, Lamers MC.

Curr Biol. 1997 Feb 1;7(2):133-43.

19.

Analysis of tyrosine phosphorylation-dependent interactions between stimulatory effector proteins and the B cell co-receptor CD22.

Yohannan J, Wienands J, Coggeshall KM, Justement LB.

J Biol Chem. 1999 Jun 25;274(26):18769-76.

20.

The B cell antigen receptor complex: mechanisms and implications of tyrosine kinase activation.

Tseng J, Lee YJ, Eisfelder BJ, Clark MR.

Immunol Res. 1994;13(4):299-310. Review.

PMID:
7542303

Supplemental Content

Support Center